Early research (Phase 1)Study completedNCT02063204
What this trial is testing
To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects
Who this might be right for
Solid Tumours
AstraZeneca 24